Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-30 | Edmund P. Harrigan, M.D.(7) Fees Earned or Paid in Cash includes Annual Retainer of $50,000. Option Awards includes the fair value of 15,000 stock options granted June 13, 2017 with an exercise price of $27.25 and the fair value of 15,000 stock options granted July 17, 2017 with an exercise price of $28.85 for being a member of the Scientific Committee. As of December 31, 2017, an aggregate of 57,500 stock options that had been granted to Dr. Harrigan were outstanding. |
| 2020-04-29 | Edmund P. Harrigan, M.D., age 67, has served as a director of our company since November 2015... The following table shows, for the fiscal year ended December 31, 2019, certain information with respect to the compensation of all non-employee directors of the Company during 2019... Edmund P. Harrigan, M.D.: Fees Earned or Paid in Cash $50,000, Option Awards $322,439, Total $372,439. |
| 2021-04-30 | Edmund P. Harrigan, M.D. 68 Director ... "Fees Earned or Paid in Cash" represents an annual retainer as a Board member of $50,000. "Option Awards" includes the fair value of 5,579 stock options granted June 23, 2030 with an exercise price of $52.73. "Stock Awards" includes the fair value of 3,059 restricted stock units granted June 23, 2020. As of December 31, 2020, an aggregate of 115,579 stock options and 3,059 restricted stock units that had been granted to Dr. Harrigan were outstanding. |
| 2022-04-29 | Edmund P. Harrigan, M.D. 69 Director... The following table shows, for the fiscal year ended December 31, 2021, certain information with respect to the compensation of all non-employee directors of the Company during 2021... Edmund P. Harrigan, M.D. Fees Earned or Paid in Cash $70,000, Option Awards $167,690, Stock Awards $159,008, Total $396,698. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-20 | Edmund P. Harrigan, M.D. INDEPENDENT DIRECTOR Age: 67 COMMITTEES: None DIRECTOR SINCE: 2019 Edmund P. Harrigan, M.D. joined the Board in December 2019. Dr. Harrigan served as Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. |
| 2021-04-16 | Edmund P. Harrigan, M.D. joined the Board in December 2019. Dr. Harrigan served as Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. from 2012 until his retirement in 2015. |
| 2022-04-29 | Edmund P. Harrigan, M.D. joined the Board in December 2019. Dr. Harrigan served as Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. from 2012 until his retirement in 2015. Dr. Harrigan’s previous executive leadership roles at Pfizer included serving as Senior Vice President, Head of Worldwide Business Development, Senior Vice President, Head of Worldwide Regulatory Affairs and Quality Assurance, and Vice President, Head of Neuroscience and Ophthalmology. Previously, Dr. Harrigan served in senior leadership positions at Karuna Pharmaceuticals, Inc., Sepracor Inc., and Neurogen Corporation. Prior to entering the pharmaceutical industry in 1990, Dr. Harrigan was a practicing neurologist for seven years. The Board has concluded that Edmund P. Harrigan should serve on the Board because he has significant executive leadership experience in the pharmaceutical and biotechnology industry, including experience in drug discovery and development, regulatory affairs and business development. Dr. Harrigan also brings substantial medical and scientific experience to the Board. In addition, Dr. Harrigan has significant experience serving as a director of other publicly held life sciences companies. Other Public Company Boards: Current ACADIA Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Past 5 Years Bellicum Pharmaceuticals, Inc. (2018-2019) Karuna Therapeutics, Inc. (2011-2020) |
| 2023-04-28 | Edmund P. Harrigan, M.D., Independent Director, Former Senior Vice President of Worldwide Safety and Regulatory, Pfizer Inc., Age: 70, Director Since: 2019, Committees: Science and Technology (Chair), Audit and Finance, 2022 Director Compensation Table: Total $451,218 |
| 2024-04-29 | Edmund P. Harrigan, M.D. INDEPENDENT DIRECTOR Age: 71 COMMITTEES: Science and Technology (Chair), Audit and Finance DIRECTOR SINCE: 2019 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22